Efficacy and Safety of Qili Qiangxin Capsule on Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis of 35 Randomized Controlled Trials

Objective: Qili Qiangxin Capsule (QQC), a Chinese patent medicine, is clinically effective in treating dilated cardiomyopathy (DCM). However, the meta-analysis of QCC combined with conventional western medicine (CWM) on DCM remains unexplored. This study aimed to systematically evaluate the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jingjing, Li, Bin, Wang, Xinlu, Li, Xingyuan, Hu, Yucai, Qiao, Lijie, Zhou, Cheng, Yu, Peng, Sang, Tianqing, Zhu, Mingjun, Wang, Yongxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095857/
https://www.ncbi.nlm.nih.gov/pubmed/35571117
http://dx.doi.org/10.3389/fphar.2022.893602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095857/
https://www.ncbi.nlm.nih.gov/pubmed/35571117
http://dx.doi.org/10.3389/fphar.2022.893602

Ejemplares similares